1. Home
  2. ETS vs PHGE Comparison

ETS vs PHGE Comparison

Compare ETS & PHGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ETS
  • PHGE
  • Stock Information
  • Founded
  • ETS 2020
  • PHGE 2015
  • Country
  • ETS United States
  • PHGE Israel
  • Employees
  • ETS N/A
  • PHGE N/A
  • Industry
  • ETS Trucking Freight/Courier Services
  • PHGE Biotechnology: Pharmaceutical Preparations
  • Sector
  • ETS Industrials
  • PHGE Health Care
  • Exchange
  • ETS Nasdaq
  • PHGE Nasdaq
  • Market Cap
  • ETS 14.7M
  • PHGE 15.5M
  • IPO Year
  • ETS 2025
  • PHGE N/A
  • Fundamental
  • Price
  • ETS $0.72
  • PHGE $0.49
  • Analyst Decision
  • ETS
  • PHGE Strong Buy
  • Analyst Count
  • ETS 0
  • PHGE 1
  • Target Price
  • ETS N/A
  • PHGE $15.00
  • AVG Volume (30 Days)
  • ETS 127.8K
  • PHGE 427.0K
  • Earning Date
  • ETS 10-14-2025
  • PHGE 11-12-2025
  • Dividend Yield
  • ETS N/A
  • PHGE N/A
  • EPS Growth
  • ETS N/A
  • PHGE N/A
  • EPS
  • ETS N/A
  • PHGE N/A
  • Revenue
  • ETS $2,585,885.00
  • PHGE N/A
  • Revenue This Year
  • ETS N/A
  • PHGE N/A
  • Revenue Next Year
  • ETS N/A
  • PHGE N/A
  • P/E Ratio
  • ETS N/A
  • PHGE N/A
  • Revenue Growth
  • ETS 6.59
  • PHGE N/A
  • 52 Week Low
  • ETS $0.70
  • PHGE $0.34
  • 52 Week High
  • ETS $4.23
  • PHGE $1.16
  • Technical
  • Relative Strength Index (RSI)
  • ETS N/A
  • PHGE 36.59
  • Support Level
  • ETS N/A
  • PHGE $0.55
  • Resistance Level
  • ETS N/A
  • PHGE $0.61
  • Average True Range (ATR)
  • ETS 0.00
  • PHGE 0.04
  • MACD
  • ETS 0.00
  • PHGE -0.01
  • Stochastic Oscillator
  • ETS 0.00
  • PHGE 0.00

About ETS Elite Express Holding Inc. Class A Common Stock

Elite Express Holding Inc is a holding company that operates through its wholly owned subsidiary and specializes in last-mile delivery services within California. Its core business focuses on retrieving packages from distribution hubs and ensuring their prompt and secure delivery to recipients' doorsteps. Committed to innovation and efficiency, its mission is to optimize last-mile logistics by providing efficient, reliable, and innovative delivery solutions. The company mainly competes in the route delivery industry, which has several material barriers of entry, including: Substantial time and capital investment, Technological proficiency, Regulatory barriers, Balancing service quality and cost efficiency, and Effective Management.

About PHGE BiomX Inc. COmmon Stock

BiomX Inc is engaged in developing both natural and engineered phage cocktails and personalized treatments designed to target and destroy harmful bacteria in chronic diseases, including cystic fibrosis and diabetic foot osteomyelitis. It discovers and validates proprietary bacterial targets and customizes phage compositions against these targets, and applies its BOLT (BacteriOphage Lead to Treatment) platform to customize phage compositions against these targets. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF. Its BX211 - Treatment of Diabetic Foot Osteomyelitis (DFO).

Share on Social Networks: